Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Immunogenicity and Safety of 2 Schedules of ALVAC-HIV vCP1452 in Chronically HIV-Infected Patients (MANON 02)

This study has been completed.
Sponsor:
Information provided by:
Objectif Recherche Vaccins SIDA
ClinicalTrials.gov Identifier:
NCT00219362
First received: September 16, 2005
Last updated: November 24, 2009
Last verified: November 2009